BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 6782183)

  • 21. Molecular species of plasminogen activators secreted by normal and neoplastic human cells.
    Wilson EL; Becker ML; Hoal EG; Dowdle EB
    Cancer Res; 1980 Mar; 40(3):933-8. PubMed ID: 7193517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification of plasminogen activators from human seminal plasma.
    Propping D; Zaneveld LJ; Tauber PF; Schumacher GF
    Biochem J; 1978 May; 171(2):435-44. PubMed ID: 26336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasminogen activator in human tears.
    Stevens JD; Marshall JM; Benjamin L; Cederholm-Williams SA; Bron AJ
    Eye (Lond); 1992; 6 ( Pt 6)():653-8. PubMed ID: 1289146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
    Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
    Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
    Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD
    Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasminogen activators and their inhibitors in human saliva and salivary gland tissue.
    Virtanen OJ; Sirén V; Multanen J; Färkkilä M; Leivo I; Vaheri A; Koskiniemi M
    Eur J Oral Sci; 2006 Feb; 114(1):22-6. PubMed ID: 16460337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
    Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
    Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human synovial fibroblasts produce urokinase-type plasminogen activator.
    Medcalf RL; Hamilton JA
    Arthritis Rheum; 1986 Nov; 29(11):1397-401. PubMed ID: 3096341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen activators in human nasal polyps and mucosa.
    Larsen K; de Maat MP; Jespersen J
    Rhinology; 1997 Dec; 35(4):175-7. PubMed ID: 9532638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological characterization of plasminogen activators in human parotid saliva.
    Kjaeldgaard M; Kjaeldgaard A
    Arch Oral Biol; 1987; 32(12):855-7. PubMed ID: 3140770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay.
    Rijken DC; Juhan-Vague I; de Cock F; Collen D
    J Lab Clin Med; 1983 Feb; 101(2):274-84. PubMed ID: 6681623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urokinase receptor variants in tissue and body fluids.
    Høyer-Hansen G; Lund IK
    Adv Clin Chem; 2007; 44():65-102. PubMed ID: 17682340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluids.
    Braat EA; Nauland U; Dooijewaard G; Rijken DC
    Thromb Haemost; 1996 Jun; 75(6):908-14. PubMed ID: 8822585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal levels of urokinase plasminogen activator protein and tissue plasminogen activator activity in human aortic aneurysms.
    Falkenberg M; Holmdahl L; Tjärnström J; Risberg B
    Eur J Surg; 2001 Jan; 167(1):10-4. PubMed ID: 11213813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human seminal fibrinolytic activity: specific determinations of tissue plasminogen activator and urokinase.
    Van Dreden P; Gonzalès J; Poirot C
    Andrologia; 1991; 23(1):29-33. PubMed ID: 1910268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous determination of free tissue-type and free urokinase-type plasminogen activators in biological fluids by a solid-phase immunoassay.
    Kuo BS; Bjornsson TD
    Anal Biochem; 1993 Feb; 209(1):70-8. PubMed ID: 8465964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological comparison between human and rat plasminogen activators in blood and the vessel wall.
    Kjaeldgaard A; Larsson B; Astedt B
    J Clin Pathol; 1984 Oct; 37(10):1153-6. PubMed ID: 6541663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in pericardial morphology and fibrinolytic activity during cardiopulmonary bypass.
    Nkere UU; Whawell SA; Thompson EM; Thompson JN; Taylor KM
    J Thorac Cardiovasc Surg; 1993 Aug; 106(2):339-45. PubMed ID: 8341074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevation of plasminogen activators in cerebrospinal fluid of mice with eosinophilic meningitis caused by Angiostrongylus cantonensis.
    Hou RF; Tu WC; Lee HH; Chen KM; Chou HL; Lai SC
    Int J Parasitol; 2004 Nov; 34(12):1355-64. PubMed ID: 15542096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma.
    España F; Estellés A; Fernández PJ; Gilabert J; Sánchez-Cuenca J; Griffin JH
    Thromb Haemost; 1993 Dec; 70(6):989-94. PubMed ID: 8165623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.